Atp5f1b-KO Mouse
一般名
Atp5f1b-KO
製品ID
S-KO-01166
背景情報
C57BL/6NCya
系統ID
KOCMP-11947-Atp5f1b-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Atp5f1b-KO Mouse(カタログ番号S-KO-01166)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Atp5f1b-KO
系統ID
KOCMP-11947-Atp5f1b-B6N-VA
遺伝子名
製品ID
S-KO-01166
遺伝子別名
Atp5b
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conventional knockout
染色体
Chr 10
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000026459
NCBIトランスクリプトID
NM_016774
ターゲット領域
Exon 2~8
有効領域の大きさ
~4.6 kb
遺伝子研究の概要
Atp5f1b, also known as ATP synthase F1 subunit beta, is a subunit of the mitochondrial ATP synthase or complex V of the mitochondrial respiratory chain. This complex is crucial for oxidative phosphorylation, a process that generates ATP, the cell's energy currency. Mitochondrial function is essential for various biological processes, and thus Atp5f1b is of great biological importance [1,2,3,4,5,6,7,8].
Pathogenic variants in Atp5f1b have been identified. In two families, missense variants in Atp5f1b segregated with early-onset isolated dystonia, showing an autosomal dominant mode of inheritance with incomplete penetrance. Functional studies in mutant fibroblasts revealed a severe reduction of complex V activity and impaired mitochondrial membrane potential despite no decrease in Atp5f1B protein amount, suggesting a dominant-negative effect [1]. Additionally, a de novo heterozygous variant in Atp5f1b was found in identical twin boys with congenital hypermetabolism. Expression of the mutant allele in human cell lines recapitulated the phenotype of elevated oxygen consumption and decreased mitochondrial membrane potential, indicating an autosomal dominant mitochondrial uncoupling syndrome with hypermetabolism [5]. A Mendelian randomization analysis also showed a positive causal relationship between Atp5f1b and diabetic ketoacidosis, suggesting that excessive ATP production related to Atp5f1b in diabetic patients may increase the risk of this severe complication [7].
In conclusion, Atp5f1b is vital for mitochondrial ATP synthesis. Studies on Atp5f1b-related variants in human subjects have revealed its role in conditions such as isolated dystonia, congenital hypermetabolism, and diabetic ketoacidosis. These findings contribute to understanding the molecular mechanisms underlying these diseases and may potentially lead to new therapeutic strategies.
References:
1. Nasca, Alessia, Mencacci, Niccolò E, Invernizzi, Federica, Garavaglia, Barbara, Ghezzi, Daniele. . Variants in ATP5F1B are associated with dominantly inherited dystonia. In Brain : a journal of neurology, 146, 2730-2738. doi:10.1093/brain/awad068. https://pubmed.ncbi.nlm.nih.gov/36860166/
2. Zhang, Tai-Mei, Liao, Li, Yang, Shao-Ying, Shao, Zhi-Min, Li, Da-Qiang. 2022. TOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progression. In Autophagy, 19, 805-821. doi:10.1080/15548627.2022.2103992. https://pubmed.ncbi.nlm.nih.gov/35920704/
3. Ponsford, Amy H, Ryan, Thomas A, Raimondi, Andrea, Swan, Laura E, Stagi, Massimiliano. 2020. Live imaging of intra-lysosome pH in cell lines and primary neuronal culture using a novel genetically encoded biosensor. In Autophagy, 17, 1500-1518. doi:10.1080/15548627.2020.1771858. https://pubmed.ncbi.nlm.nih.gov/32515674/
4. Wauters, Fieke, Cornelissen, Tom, Imberechts, Dorien, Vangheluwe, Peter, Vandenberghe, Wim. 2019. LRRK2 mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10. In Autophagy, 16, 203-222. doi:10.1080/15548627.2019.1603548. https://pubmed.ncbi.nlm.nih.gov/30945962/
5. Ganetzky, Rebecca D, Markhard, Andrew L, Yee, Irene, To, Tsz-Leung, Mootha, Vamsi K. . Congenital Hypermetabolism and Uncoupled Oxidative Phosphorylation. In The New England journal of medicine, 387, 1395-1403. doi:10.1056/NEJMoa2202949. https://pubmed.ncbi.nlm.nih.gov/36239646/
6. Hu, Chenxi, Zheng, Zaosong, Pang, Shiyu, Wang, Qiong, Tan, Wanlong. 2024. Chimeric SFT2D2-TBX19 Promotes Prostate Cancer Progression by Encoding TBX19-202 Protein and Stabilizing Mitochondrial ATP Synthase through ATP5F1A Phosphorylation. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2408426. doi:10.1002/advs.202408426. https://pubmed.ncbi.nlm.nih.gov/39540264/
7. Xie, Ruiqiang, Xie, Hongyan, Gao, Hong, Yuan, Haipo, Feng, Zhijun. 2024. Mitochondrial proteins as therapeutic targets in diabetic ketoacidosis: evidence from Mendelian randomization analysis. In Frontiers in pharmacology, 15, 1448505. doi:10.3389/fphar.2024.1448505. https://pubmed.ncbi.nlm.nih.gov/39469619/
8. Zhiyan, Chen, Min, Zhan, Yida, Du, Huan, Wang, Linjuan, Sun. 2024. Bioinformatic analysis of hippocampal histopathology in Alzheimer's disease and the therapeutic effects of active components of traditional Chinese medicine. In Frontiers in pharmacology, 15, 1424803. doi:10.3389/fphar.2024.1424803. https://pubmed.ncbi.nlm.nih.gov/39221152/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
